Amplified genes in cancer in upper digestive tract

Semin Cancer Biol. 1993 Feb;4(1):33-40.

Abstract

Gene amplification in stomach and oesophageal cancers was reviewed. In stomach cancers, two receptor type tyrosine kinases, c-erbB-2 and K-sam, are frequently amplified and overexpressed. c-erbB-2 seems to be preferentially amplified in well-differentiated, and K-sam in poorly-differentiated, gastric adenocarcinomas. 11q13 genes are amplified in about 50% of the oesophageal cancers. These genes include hst-1, int-2 and cyclin D/prad1, all of which are mapped to chromosome 11 at band q13. Although hst-1 and int-2 are usually not expressed despite amplification, elevated transcription of the cyclin D gene is accompanied by its amplification, suggesting a role of a G1 cyclin in oesophageal carcinogenesis.

Publication types

  • Review

MeSH terms

  • ErbB Receptors / genetics
  • Esophageal Neoplasms / genetics*
  • Fibroblast Growth Factor 3
  • Fibroblast Growth Factor 4
  • Fibroblast Growth Factors / genetics
  • Gene Amplification*
  • Humans
  • Neoplasm Proteins / genetics*
  • Oncogenes*
  • Proto-Oncogene Proteins / genetics
  • Receptor Protein-Tyrosine Kinases*
  • Receptor, ErbB-2
  • Receptor, Fibroblast Growth Factor, Type 2
  • Receptors, Fibroblast Growth Factor*
  • Stomach Neoplasms / genetics*
  • Transcription, Genetic

Substances

  • FGF3 protein, human
  • FGF4 protein, human
  • Fibroblast Growth Factor 3
  • Fibroblast Growth Factor 4
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factors
  • ErbB Receptors
  • FGFR2 protein, human
  • Receptor Protein-Tyrosine Kinases
  • Receptor, ErbB-2
  • Receptor, Fibroblast Growth Factor, Type 2